Yes, in "biotech dollars" as we say. as for the rest, it is good you feel it was informative, but I think it is still specualtive- at the end of the day these theories about PD-1 or CTLA4 with Immunpulse vs Tvec will have to be proven in the clinic. Please not the the Amgen trial is already enrolling patients.
News 
Market Data 
Discover 
